AC Immune (ACIU) Q4 2025 Earnings — Mixed Results

Screener

Reported March 13, 2026 · Before market open

Revenue$426.4KMiss by $1.0M

EPS-$0.18Beat by $0.01

Revenue estimate$1.4M

EPS estimate-$0.19

Next report

Nov 3, 2026 (in 3 months)

Revenue estimate$249.7K

EPS estimate-$0.22

Versus estimates

Revenue

Q2 2026$9.8MBeat by $245.5K Q1 2026$1.4MBeat by $1.1M

Q4 2025$426.4KMiss by $1.0M

Q3 2025$1.2MBeat by $36.9K Q2 2025$1.6MBeat by $1.3M Q1 2025$1.2MBeat by $688.8K

Diluted EPS

Q2 2026$0.03Beat by $0.13 Q1 2026-$0.19Beat by $0.01

Q4 2025-$0.18Beat by $0.01

Q3 2025-$0.20Beat by $0.02 Q2 2025-$0.25Miss by $0.05 Q1 2025-$0.21Beat by $0.01

FAQ

When did AC Immune report Q4 2025 earnings?: AC Immune (ACIU) reported Q4 2025 earnings on March 13, 2026 before market open.
What were AC Immune's Q4 2025 revenue and EPS?: AC Immune reported revenue of $426.4K and eps of $-0.18 for Q4 2025.
Did AC Immune beat estimates in Q4 2025?: Revenue missed the consensus estimate of $1.4M by $1.0M. EPS beat the consensus estimate of $-0.19 by $0.01.
How did AC Immune's Q4 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue declined 65.9% from $1.3M a year earlier and eps grew 0.0% from $-0.18.

Ask the moment AC Immune reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Harbor at dusk